Therapeutic Areas: Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Immunology | Infections and Infectious Diseases

Allergy Clinical Trials


A listing of Allergy medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Research Site New

Asthma Clinical Research Study

Foley : Research Site Updated

Asthma Clinical Research Study

Mobile : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Arizona

Flagstaff : Research Site Updated

Asthma Clinical Research Study

Glendale : Research Site Updated

Asthma Clinical Research Study

Tucson : Research Site Updated

Asthma Clinical Research Study

Arkansas

Little Rock : Research Site New

Asthma Clinical Research Study

California

Anaheim : Research Site New

Asthma Clinical Research Study

Bakersfield : Research Site Updated

Asthma Clinical Research Study

Burbank : Research Site New

Asthma Clinical Research Study

Costa Mesa : Research Site New

Asthma Clinical Research Study

Encinitas : Research Site New

Asthma Clinical Research Study

Fountain Valley : Research Site Updated

Asthma Clinical Research Study

Garden Grove : Research Site Updated

Asthma Clinical Research Study

Granada Hills : Research Site Updated

Asthma Clinical Research Study

Long Beach : Research Site Updated

Asthma Clinical Research Study

Long Beach : Research Site Updated

Asthma Clinical Research Study

Los Angeles : UCLA

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Los Angeles : Research Site Updated

Asthma Clinical Research Study

Los Angeles : Research Site Updated

Asthma Clinical Research Study

Napa : Research Site Updated

Asthma Clinical Research Study

Newport Beach : Research Site Updated

Asthma Clinical Research Study

Orange : Research Site Updated

Asthma Clinical Research Study

Redondo Beach : Research Site Updated

Asthma Clinical Research Study

Redwood City : Research Site Updated

Asthma Clinical Research Study

Riverside : Research Site Updated

Asthma Clinical Research Study

Rolling Hills Estates : Research Site New

Asthma Clinical Research Study

San Diego : Research Site New

Asthma Clinical Research Study

San Diego : Research Site Updated

Asthma Clinical Research Study

San Jose : Research Site Updated

Asthma Clinical Research Study

Thousand Oaks : Research Site Updated

Asthma Clinical Research Study

Wildomar : Elite Clinical Trials, Inc.

Does Your Child Suffer from Allergies or Hives?

Fresno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Riverside : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

San Jose : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Colorado

Centennial : Research Site Updated

Asthma Clinical Research Study

Colorado Springs : Research Site Updated

Asthma Clinical Research Study

Denver : National Jewish Health

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Denver : Research Site Updated

Asthma Clinical Research Study

Wheat Ridge : Research Site Updated

Asthma Clinical Research Study

Connecticut

Waterbury : Research Site Updated

Asthma Clinical Research Study

Waterbury : Research Site Updated

Asthma Clinical Research Study

Florida

Aventura : Research Site Updated

Asthma Clinical Research Study

Coral Gables : Research Site New

Asthma Clinical Research Study

Fort Lauderdale : Research Site Updated

Asthma Clinical Research Study

Hialeah : Research Site Updated

Asthma Clinical Research Study

Lynn Haven : Research Site Updated

Asthma Clinical Research Study

Miami : Research Site Updated

Asthma Clinical Research Study

Miami : Research Site Updated

Asthma Clinical Research Study

Miami : Research Site Updated

Asthma Clinical Research Study

Miami Beach : Research Site Updated

Asthma Clinical Research Study

New Port Richey : Research Site New

Asthma Clinical Research Study

Panama City : Research Site Updated

Asthma Clinical Research Study

Sarasota : Research Site Updated

Asthma Clinical Research Study

Tallahassee : Research Site Updated

Asthma Clinical Research Study

Winter Park : Research Site Updated

Asthma Clinical Research Study

Georgia

Columbus : Research Site Updated

Asthma Clinical Research Study

Decatur : Research Site Updated

Asthma Clinical Research Study

Gainesville : Research Site Updated

Asthma Clinical Research Study

Marietta : Research Site Updated

Asthma Clinical Research Study

Savannah : Research Site Updated

Asthma Clinical Research Study

Smyrna : Research Site Updated

Asthma Clinical Research Study

Stockbridge : Research Site Updated

Asthma Clinical Research Study

Hawaii

Honolulu : Research Site Updated

Asthma Clinical Research Study

Idaho

Eagle : Research Site Updated

Asthma Clinical Research Study

Twin Falls : Research Site Updated

Asthma Clinical Research Study

Illinois

Chicago : ChicagoENT

A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

Chicago : University of Chicago New

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Chicago : Northwestern University

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Chicago : University of Chicago

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Indiana

Fort Wayne : Research Site Updated

Asthma Clinical Research Study

Kansas

Lenexa : Research Site New

Asthma Clinical Research Study

Kentucky

Bowling Green : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Maine

Bangor : Research Site Updated

Asthma Clinical Research Study

Maryland

Baltimore : Johns Hopkins New

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Baltimore : Johns Hopkins

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Baltimore : Research Site Updated

Asthma Clinical Research Study

Baltimore : PAREXEL

Seasonal Allergy Eczema

Bethesda : Research Site New

Asthma Clinical Research Study

Wheaton : Research Site New

Asthma Clinical Research Study

White Marsh : Research Site New

Asthma Clinical Research Study

White Marsh : Research Site New

Asthma Clinical Research Study

Columbia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Waldorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Massachusetts

North Dartmouth : Research Site Updated

Asthma Clinical Research Study

Minnesota

Minneapolis : Clinical Research Institute, MN

810_Cow's Milk Allergy Research Study

Minneapolis : Research Site Updated

Asthma Clinical Research Study

Minneapolis : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Missouri

Chesterfield : Research Site Updated

Asthma Clinical Research Study

Kansas City : Research Site Updated

Asthma Clinical Research Study

Rolla : Research Site New

Asthma Clinical Research Study

St. Louis : Research Site Updated

Asthma Clinical Research Study

St. Louis : Research Site New

Asthma Clinical Research Study

St. Louis : The Clinical Research Center, LLC

Do You Suffer from Dust Mite Allergies? If so You May Quailfy for a House Dust Mite Study.

Warrensburg : Research Site New

Asthma Clinical Research Study

Montana

Bozeman : Research Site New

Asthma Clinical Research Study

Missoula : Research Site New

Asthma Clinical Research Study

Nebraska

Bellevue : Research Site Updated

Asthma Clinical Research Study

Omaha : Research Site Updated

Asthma Clinical Research Study

Papillion : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nevada

Las Vegas : Research Site Updated

Asthma Clinical Research Study

Las Vegas : Research Site Updated

Asthma Clinical Research Study

New Jersey

Edison : Research Site Updated

Asthma Clinical Research Study

Ocean : Research Site Updated

Asthma Clinical Research Study

Skillman : Research Site Updated

Asthma Clinical Research Study

Verona : Research Site Updated

Asthma Clinical Research Study

New York

Bronx : The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore

Diagnosis of Aspirin Hypersensitivity by Measuring Arachidonic Acid Metabolites after Low Dose Aspirin Challenge

Great Neck : Research Site Updated

Asthma Clinical Research Study

Mineola : Research Site Updated

Asthma Clinical Research Study

Mineola : Winthrop University Hospital Clinical Trials Center

Children and Adolescents with Hereditary Angioedema (HAE)

Mineola : Winthrop University Hospital Clinical Trials Center

Study for adults with Hereditary Angioedema (HAE)

New York : The Rockefeller University Hospital

Food Allergy, Phenotype, Regulation and Development of the Immune System in Adult Atopic Dermatitis Patients

Rockville Centre : Research Site New

Asthma Clinical Research Study

Brooklyn : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

North Carolina

Asheville : Research Site Updated

Asthma Clinical Research Study

Chapel Hill : UNC Chapel Hill New

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Charlotte : Research Site New

Asthma Clinical Research Study

High Point : Research Site Updated

Asthma Clinical Research Study

Huntersville : Research Site Updated

Asthma Clinical Research Study

Wilmington : Research Site Updated

Asthma Clinical Research Study

Wilmington : Research Site Updated

Asthma Clinical Research Study

Ohio

Cincinnati : Research Site Updated

Asthma Clinical Research Study

Cincinnati : Research Site New

Asthma Clinical Research Study

Dayton : Research Site Updated

Asthma Clinical Research Study

Kettering : Research Site Updated

Asthma Clinical Research Study

Sylvania : Research Site New

Asthma Clinical Research Study

Toledo : Research Site Updated

Asthma Clinical Research Study

Toledo : Research Site New

Asthma Clinical Research Study

Cincinnati : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Oklahoma

Oklahoma City : Research Site Updated

Asthma Clinical Research Study

Tulsa : Research Site New

Asthma Clinical Research Study

Oregon

Eugene : Research Site Updated

Asthma Clinical Research Study

Lake Oswego : Research Site New

Asthma Clinical Research Study

Medford : Research Site New

Asthma Clinical Research Study

Portland : Research Site Updated

Asthma Clinical Research Study

Medford : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pennsylvania

Altoona : Research Site Updated

Asthma Clinical Research Study

Jenkintown : Research Site New

Asthma Clinical Research Study

Philadelphia : Research Site Updated

Asthma Clinical Research Study

Pittsburgh : Research Site Updated

Asthma Clinical Research Study

Pittsburgh : Research Site New

Asthma Clinical Research Study

Sellersville : Research Site Updated

Asthma Clinical Research Study

Smithfield : Research Site New

Asthma Clinical Research Study

Upland : Research Site Updated

Asthma Clinical Research Study

Philadelphia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rhode Island

East Providence : Research Site New

Asthma Clinical Research Study

South Carolina

Greenville : Research Site Updated

Asthma Clinical Research Study

Greenville : Research Site Updated

Asthma Clinical Research Study

Spartanburg : Research Site Updated

Asthma Clinical Research Study

Mt. Pleasant : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Summerville : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tennessee

Knoxville : Research Site Updated

Asthma Clinical Research Study

Texas

Austin : Research Site Updated

Asthma Clinical Research Study

Austin : Research Site Updated

Asthma Clinical Research Study

Austin : Research Site Updated

Asthma Clinical Research Study

Boerne : Research Site New

Asthma Clinical Research Study

Dallas : Research Site Updated

Asthma Clinical Research Study

Dallas : Research Site New

Asthma Clinical Research Study

Edinburg : Research Site Updated

Asthma Clinical Research Study

El Paso : Research Site Updated

Asthma Clinical Research Study

El Paso : Research Site New

Asthma Clinical Research Study

Georgetown : Research Site Updated

Asthma Clinical Research Study

Houston : Research Site New

Asthma Clinical Research Study

Houston : Research Site Updated

Asthma Clinical Research Study

Live Oak : Research Site Updated

Asthma Clinical Research Study

New Braunfels : Research Site New

Asthma Clinical Research Study

San Antonio : Research Site Updated

Asthma Clinical Research Study

San Antonio : Research Site Updated

Asthma Clinical Research Study

San Antonio : Research Site Updated

Asthma Clinical Research Study

San Antonio : Research Site Updated

Asthma Clinical Research Study

San Antonio : Research Site New

Asthma Clinical Research Study

San Antonio : Research Site Updated

Asthma Clinical Research Study

San Antonio : Research Site Updated

Asthma Clinical Research Study

Sugar land : Research Site Updated

Asthma Clinical Research Study

Sugar Land : Research Site Updated

Asthma Clinical Research Study

Waco : Research Site New

Asthma Clinical Research Study

Arlington : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Utah

Murray : Research Site Updated

Asthma Clinical Research Study

Salt Lake City : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Vermont

South Burlington : Research Site New

Asthma Clinical Research Study

Virginia

Abingdon : Research Site Updated

Asthma Clinical Research Study

Fairfax : Research Site Updated

Asthma Clinical Research Study

Henrico : Research Site New

Asthma Clinical Research Study

Henrico : Research Site Updated

Asthma Clinical Research Study

Midlothian : Virginia Research Center

SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

Richmond : Virginia Research Center

SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

Fairfax : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Washington

Bellingham : Research Site Updated

Asthma Clinical Research Study

Seattle : ASTHMA, Inc.

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Seattle : ASTHMA, Inc. New

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Seattle : Research Site Updated

Asthma Clinical Research Study

Spokane : Research Site Updated

Asthma Clinical Research Study

Tacoma : Research Site New

Asthma Clinical Research Study

Everett : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Wisconsin

Greenfield : Research Site New

Asthma Clinical Research Study

Madison : University of Wisconsin Madison

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Madison : University of Wisconsin – Madison New

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Madison : Research Site Updated

Asthma Clinical Research Study

Argentina

Buenos Aires : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Buenos Aires : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mar del Plata : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mendoza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mendoza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rosario : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rosario : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

San Miguel de Tucuman : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Santa Fe : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Santa Fe : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Canada

Montreal : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ottawa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Quebec : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St-Charles-Borromée : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Czech Republic

Breclav : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Olomouc : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tabor : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Teplice : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Trutnov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Denmark

Finland

Helsinki : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tampere : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Turku : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

France

Le Kremlin Bicetre : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Marseille : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Germany

Berlin : Hospital Charité

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Bonn : St.-Marien-Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Frankfurt : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Grosshansdorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Hamburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Homburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Leipzig : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Leipzig : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mainz : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Roth : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rüdersdorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Hungary

Budapest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Debrecen : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Godollo : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pecs : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Torokbalint : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Israel

Haifa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Jerusalem : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Jerusalem : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kfar-Sava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Petach Tikva : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rehovot : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Italy

Messina : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Milano : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Padova : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pisa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Reggio Emilia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Verona : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Korea, Republic of

Bucheon-Si : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cheongju : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Gwangju : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Suwon : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mexico

Guadalajara : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

México, D.F. : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Poland

Bialystok : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lodz : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Portugal

Coimbra : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lisboa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lisboa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Porto : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Vila Nova de Gaia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Romania

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucuresti : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucuresti : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cluj Napoca : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cluj-Napoca : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Constanta : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Russian Federation

Barnaul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

N.Novgorod : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nizhny Novgorod : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ryazan : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Sankt-Peterburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Saratov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St. Petersburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St-Petersburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Yaroslavl : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Slovakia

Bratislava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bratislava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kosice : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nitra : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Prievidza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ruzomberok : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Trencin : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Spain

Granada : Biosearch S.A.

A clinical trial to evaluate treatments using Damira/Celia peptide hydrolyzed casein and Picot riz/Celia rice/Sanutri arroz for patients with Cow Milk Protein Sensitivity, Tolerance or Growth Failure

Turkey

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Izmir : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mersin : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

United Kingdom

Birmingham : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bradford : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

East Yorkshire : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

London : Evelina Children's Hospital - St Thomas' Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Merthyr Tydfil : Simbec Research

A clinical research study of ATX2417 and Placebo for the treatment of Allergy

Newcastle upon Tyne : Newcastle general hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Newport : David Hyde Allergy Clinic - St. Mary's hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Southampton : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Southampton : Southampton General Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy